Four FDA-Approved Weight-Loss Medicines Target Parts Of The Brain Involved With Appetite, Satiety.

The drugs all target parts of the brain involved with appetite and satiety, and interfere with hunger signals, explains Eric Ravussin, a physiologist at the Pennington Biomedical Research Center in Baton Rouge, Louisiana. So they can reduce the chances that you'll overeat. Belviq is a new drug, while Qsymia is a combination of two older drugs, phentermine and the anti-seizure medication topiramate. Contrave is a combination of naltrexone, used to combat drug and alcohol addiction, and bupropion, prescribed as Wellbutrin for depression and as Zyban for smoking cessation. Saxenda is a higher dose of the diabetes drug Victoza http://health.usnews.com/health-news/health-wellness/articles/2015/08/26/the-new-obesity-drugs-an-rx-for-weight-loss